Enhanced monitoring of tenofovir-lamivudine-dolutegravir (TLD) replacing first-line HIV-antiretroviral treatment in Chiradzulu District, Malawi (EMEDT)

The aim of the study was to conduct enhanced monitoring in parallel to the national TLD roll out. The findings were expected to inform the mass rollout of TLD with specific focus on outcomes of the “blind transitioning” (without prior VL test) app...